aliskiren

renin ; Homo sapiens







391 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
301 18625162 Direct renin inhibition: an analysis of possible benefits. 2008 Aug 2
302 18662494 Effect of aliskiren, an oral direct renin inhibitor, on the pharmacokinetics and pharmacodynamics of a single dose of acenocoumarol in healthy volunteers. 2008 Sep 1
303 18687166 Direct renin inhibition: an evaluation of the safety and tolerability of aliskiren. 2008 Sep 2
304 18695203 Aliskiren. 2008 Aug 12 1
305 18695389 Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients? 2008 Sep 1
306 18698213 Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren. 2008 Sep 2
307 18704745 Inhibition of the renin-angiotensin system and chronic kidney disease. 2008 1
308 18764720 The development of the direct renin inhibitor aliskiren: treating hypertension and beyond. 2008 Sep 3
309 18765089 Now that we have a direct renin inhibitor, what should we do with it? 2008 Jun 1
310 18784280 Pharmacokinetics of the oral direct renin inhibitor aliskiren in combination with digoxin, atorvastatin, and ketoconazole in healthy subjects: the role of P-glycoprotein in the disposition of aliskiren. 2008 Nov 2
311 18786303 A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects. 2008 Aug 2
312 18802783 First renin inhibitor, aliskiren, for the treatment of hypertension. 2008 Dec 2
313 18843743 Blood pressure lowering efficacy of renin inhibitors for primary hypertension. 2008 Oct 8 1
314 18929229 Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering? 2008 Nov 1
315 18957387 Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension. 2008 Sep 2
316 18981317 Aliskiren accumulates in Renin secretory granules and binds plasma prorenin. 2008 Dec 8
317 19035874 Pharmacokinetic interaction of the direct renin inhibitor aliskiren with furosemide and extended-release isosorbide-5-mononitrate in healthy subjects. 2008 Winter 1
318 19051513 [Aliskiren (Rasilez), direct renin inhibitor]. 2008 Sep 2
319 19066408 Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor. 2008 Sep-Oct 3
320 19183745 The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction. 2008 1
321 19203020 Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders. 2008 Dec 1
322 19212031 Aliskiren: a novel renin inhibitor for hypertension. 2008 Jan-Feb 2
323 19337534 Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy. 2008 3
324 19808266 Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure. 2008 May 1
325 23355128 Cardiovascular risk in hypertension - can we ask for more? : focus on aliskiren. 2008 Oct 2
326 17143194 Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide. 2007 Jan 3
327 17159081 Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker. 2007 Feb 3
328 17198906 Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan. 2007 Jan 2
329 17244770 Pharmacokinetics, safety, and tolerability of the oral Renin inhibitor aliskiren in patients with hepatic impairment. 2007 Feb 2
330 17341529 Aliskiren for renin inhibition: a new class of antihypertensives. 2007 Mar 2
331 17352858 [Global treatment of cardiovascular risk in the hypertensive patient]. 2007 Feb 1
332 17353513 Direct Renin inhibition with aliskiren in obese patients with arterial hypertension. 2007 May 1
333 17376010 Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution? 2007 Apr 2
334 17389554 Pharmacokinetics, safety, and tolerability of the novel oral direct renin inhibitor aliskiren in elderly healthy subjects. 2007 Apr 1
335 17401311 Expanding the opportunities for blocking the renin-angiotensin system: introduction to a special supplement. 2007 1
336 17401313 The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension. 2007 2
337 17485026 Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness. 2007 May 6
338 17510248 Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteers. 2007 Aug 2
339 17541390 A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension. 2007 Oct 1
340 17578167 [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?]. 2007 Apr 2
341 17590217 Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension. 2007 Sep 2
342 17655373 Pharmacokinetics of the oral direct renin inhibitor aliskiren alone and in combination with irbesartan in renal impairment. 2007 2
343 17658393 Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial. 2007 Jul 21 1
344 17673883 Direct renin inhibitors: a new approach to antihypertensive drug treatment. 2007 Aug 1
345 17686379 Renin inhibition: a new modality for hypertension management. 2007 Aug 1
346 17700383 Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren. 2007 Sep-Oct 3
347 17702736 Hormonal and hemodynamic effects of aliskiren and valsartan and their combination in sodium-replete normotensive individuals. 2007 Sep 3
348 17703126 Novel drugs targeting hypertension: renin inhibitors. 2007 Aug 1
349 17824680 Structural modification of the P2' position of 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets. 2007 Oct 4 1
350 17867914 Aliskiren, the future of renin-angiotensin system blockade? 2007 Sep 3